Artículo

Estamos trabajando para incorporar este artículo al repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Registro:

Documento: Artículo
Título:Conversion of recent onset atrial fibrillation: Which drug is faster?
Autor:Conde, D.
Filiación:Instituto Cardiovascular de Buenos Aires, Blanco Encalada 1543, 1428 Buenos Aires, Argentina
Palabras clave:amiodarone; flecainide; propafenone; vernakalant; drug efficacy; emergency care; heart atrium fibrillation; human; letter; loading drug dose; priority journal; response time; single drug dose; sinus rhythm; treatment outcome; Administration, Oral; Amiodarone; Anisoles; Anti-Arrhythmia Agents; Atrial Fibrillation; Flecainide; Humans; Injections, Intravenous; Propafenone; Pyrrolidines; Time Factors
Año:2013
Volumen:31
Número:9
Página de inicio:1410
Página de fin:1411
DOI: http://dx.doi.org/10.1016/j.ajem.2013.05.039
Título revista:American Journal of Emergency Medicine
Título revista abreviado:Am. J. Emerg. Med.
ISSN:07356757
CODEN:AJEME
CAS:amiodarone, 1951-25-3, 19774-82-4, 62067-87-2; flecainide, 54143-55-4; propafenone, 34183-22-7, 54063-53-5; vernakalant, 748810-28-8, 794466-70-9; Amiodarone, 1951-25-3; Anisoles; Anti-Arrhythmia Agents; Flecainide, 54143-55-4; Propafenone, 54063-53-5; Pyrrolidines; vernakalant, 9G468C8B13
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_07356757_v31_n9_p1410_Conde

Referencias:

  • Boriani, G., Capucci, A., Lenzi, T., Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration (1995) Chest, 108, pp. 355-358
  • Conde, D., Costabel, J.P., Aragon, M., Flecainide or propafenone vs vernakalant for conversion of recent-onset atrial fibrillation (2013) Can J Cardiol
  • Conde, D., Costabel, J.P., Caro, M., Flecainide versus vernakalant for conversion of recent-onset atrial fibrillation (2013) Int J Cardiol
  • Camm, A.J., Capucci, A., Hohnloser, S.H., A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation (2011) J Am Coll Cardiol, 57, pp. 313-321

Citas:

---------- APA ----------
(2013) . Conversion of recent onset atrial fibrillation: Which drug is faster?. American Journal of Emergency Medicine, 31(9), 1410-1411.
http://dx.doi.org/10.1016/j.ajem.2013.05.039
---------- CHICAGO ----------
Conde, D. "Conversion of recent onset atrial fibrillation: Which drug is faster?" . American Journal of Emergency Medicine 31, no. 9 (2013) : 1410-1411.
http://dx.doi.org/10.1016/j.ajem.2013.05.039
---------- MLA ----------
Conde, D. "Conversion of recent onset atrial fibrillation: Which drug is faster?" . American Journal of Emergency Medicine, vol. 31, no. 9, 2013, pp. 1410-1411.
http://dx.doi.org/10.1016/j.ajem.2013.05.039
---------- VANCOUVER ----------
Conde, D. Conversion of recent onset atrial fibrillation: Which drug is faster?. Am. J. Emerg. Med. 2013;31(9):1410-1411.
http://dx.doi.org/10.1016/j.ajem.2013.05.039